Mass Spectrometry In-Depth Focus 2012
Posted: 25 April 2012 | European Pharmaceutical Review | No comments yet
In this free to view Mass Spectrometry In-Depth Focus: Mass spectrometry in drug discovery – Proteomics, small molecules and metablomics; Quantification of membrane drug transporters and application in drug discovery and development; Mass spectrometry leaders roundtable…
- Mass spectrometry in drug discovery – Proteomics, small molecules and metablomics
Ana Rita Angelino and Min Yang, Department of Pharmaceutical and Biological Chemistry, UCL School of Pharmacy - Quantification of membrane drug transporters and application in drug discovery and development
Tasso Miliotis and Constanze Hilgendorf, Innovative Medicines, AstraZeneca R&D - Show preview – The 60th annual conference on Mass Spectrometry and Allied Topics
- Anthony Bristow, AstraZeneca, poses the questions for our Mass Spectrometry Leaders Roundtable
George McLeod, Market Manager, Pharmaceutical MS, Bruker Daltonics / Detlev Hochmuth, Scientific Consultant and Software Developer for MS and Chemoinformatics, Dr. Hochmuth Scientific Consulting / Alessandro Baldi, VP & General Manager, Protea Biosciences Inc / Gary Harland, Mass Spectrometry Product Manager, Waters Corporation
This Mass Spectrometry In-Depth Focus is restricted - login or subscribe free to access
Why subscribe? Join our growing community of thousands of industry professionals and gain access to:
- bi-monthly issues in print and/or digital format
- case studies, whitepapers, webinars and industry-leading content
- breaking news and features
- our extensive online archive of thousands of articles and years of past issues
- ...And it's all free!
Click here to Subscribe today Login here
Issue
Related topics
Related organisations
AstraZeneca R&D, Bruker, Dr. Hochmuth, Protea, UCL School of Pharmacy, Waters